Search Results - Shengjin Dou

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Letter to the Editor: Reply to Topkan et al. by Shengjin Dou, Guopei Zhu

    Get full text
    Article


  2. 2

    Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study by Shengjin Dou, Rongrong Li, Lin Zhang, Zhuoying Wang, Li Xie, Chenping Zhang, Guopei Zhu

    Published in Cancer Medicine (2020-03-01)
    Get full text
    Article


  3. 3

    Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a prospective cohort stu... by Wen Jiang, Wen Jiang, Wen Jiang, Shengjin Dou, Shengjin Dou, Shengjin Dou, Lin Zhang, Lin Zhang, Lin Zhang, Minjun Dong, Jiang Li, Jiang Li, Jiang Li, Ge Wang, Ge Wang, Ge Wang, Ziyue Gu, Ziyue Gu, Ziyue Gu, Yining He, Debin Sun, Rongrong Li, Rongrong Li, Rongrong Li, Guopei Zhu, Guopei Zhu, Guopei Zhu

    Published in Frontiers in Immunology (2025-10-01)
    Get full text
    Article


  4. 4

    Prognosis and Failure Patterns of 11q13 Amplified Local Advanced Squamous Cell Carcinoma of the Head and Neck by Chang Jiang, Shengjin Dou, Yu Wang, Wen Jiang, Lulu Ye, Rongrong Li, Xiaolong Fu, Lin Zhang, Guopei Zhu

    Published in Cancer Medicine (2025-09-01)
    Get full text
    Article


  5. 5

    Fusobacterium nucleatum‐Derived Outer Membrane Vesicles Promote Immunotherapy Resistance via Changes in Tryptophan Metabolism in Tumour‐Associated Macrophages by Weiping Li, Zhen Zhang, Ruoyi Wu, Mengying Mao, Yikang Ji, Xiaoning Wang, Shengjin Dou, Ming Yan, Wantao Chen

    Published in Journal of Extracellular Vesicles (2025-04-01)
    Get full text
    Article


  6. 6

    Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential... by Wen Jiang, Lan Chen, Rongrong Li, Jiang Li, Shengjin Dou, Lulu Ye, Yining He, Zhen Tian, Yanli Yao, Guopei Zhu

    Published in BMC Medicine (2024-07-01)
    Get full text
    Article


  7. 7

    Efficacy and feasibility of Apatinib and S-1 as a novel oral induction therapy in locally advanced head and neck squamous cell carcinoma: an exploratory phase 2 open-label, single-... by Wen Jiang, Rongrong Li, Lin Zhang, Shengjin Dou, Lulu Ye, Ziyang Shao, Sicheng Wu, Minjun Dong, Jiang Li, Guopei Zhu

    Published in Frontiers in Oncology (2023-05-01)
    Get full text
    Article


  8. 8

    Concurrent chemoradiotherapy versus radiotherapy alone in postoperative high-risk adenoid cystic carcinoma of the head and neck: A propensity score matched analysis by Shengjin Dou, Xin Wang, Ying Xiao, Lin Zhang, Wen Jiang, Lulu Ye, Yu Wang, Yining He, Shengwen Liu, Rongrong Li, Guopei Zhu

    Get full text
    Article


  9. 9

    Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgery by Shengjin Dou, Lin Zhang, Rongrong Li, Yanli Yao, Wen Jiang, Lulu Ye, Jingjing Sun, Jiang Li, Sicheng Wu, Laiping Zhong, Shuyang Sun, Guopei Zhu

    Get full text
    Article


Search Tools: